Since the role of MARCKS is that of partially inhibiting BcR signaling by reducing BcR clustering, this observation contributes to explaining why M-CLL, receiving less effective stimulation via BcR, may be less susceptible to TKI. The gene discussed is MARCKS; the disease is B-cell chronic lymphocytic leukemia.